Babson Diagnostics
draws a microsample of blood at retail locations rather than through home self-collection, and recently launched its BetterWay GLP-1 blood-testing panel at retail sites in Austin and Temple, Texas.
- Country
- United States
Growth
BetterWay retail microsample testing
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Home blood-analysis kits | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.